Indian ITC-HS · Tariff Item (8-digit)

HSN Code 30069300

30069300

Placebos and blinded (or double-blinded) clinical trial kits for a recognised clinical trial, put up in measured doses DRUGS AND MEDICINES ARE SUPPLIED FREE OF COST TO THE PATIENTS UNDER THE PATIENT ASSISTANCE PROGRAMME OF THE SPECIFIED PHARMACEUTICAL COMPANY: [Notifn. No. 16/2017-Cus., dt. 20.4. 2017 as amended by 83/17, 41/20, 09/22, 07/24]. In exercise of the powers conferred by sub-section (1) of section 25 of the Customs Act, 1962 (52 of 1962), the Central Government, being satisfied that it is necessary in the public interest so to do, hereby exempts the goods, falling under Chapter 30 of the First Schedule to the Customs Tariff Act, 1975 (51 of 1975), of the description specified in column (2) of the Table below, for supply under Patient Assistance Programmes specified in the corresponding entry in column (3) of the said Table, run by the pharmaceutical companies specified in the corresponding entry in column (4) of the said Table, when imported into India, from the whole of the duty of customs leviable thereon which is specified in the First Schedule to the said Customs Tariff Act, subject to the following conditions, namely:- (a) the drugs and medicines are supplied free of cost to the patients under the Patient Assistance Programme of the specified pharmaceutical company; (b) the said pharmaceutical company furnishes an undertaking to the Assistant Commissioner of Customs or the Deputy Commissioner of Customs, as the case may be, having jurisdiction, to the effect that- (i) it shall maintain the following records:- (A) name, age, gender, residence and contact details of the patient; (B) copies of valid identity proof and residence proof of the patient and the caregiver, if any, as the case may be; (C) the disease diagnosed and the prescribed dosage of drugs and medicines; (D) the drugs and medicines imported or received and consumed under the said programme; (ii) the goods shall be used for the specified purpose only; (c) The said pharmaceutical company also furnishes an undertaking to the Assistant Commissioner of Customs or Deputy Commissioner of Customs, as the case may be, having jurisdiction, to pay, in the event of failure to comply with any of the aforesaid conditions, an amount equal to the duty leviable on such goods but for the exemption contained in this notification, along with the applicable interest thereon. TABLE Sr. Description of drug Name of Patient Name of No. / medicine Assistance Programme pharmaceutical company running Patient Assistance Programme 1. Xtandi (Enzulatamide) Xtandi Patient Assistance Programme Astellas Pharma India Pvt. Ltd. 2. Dasatinib (Sprycel) Sprycel Assistance Program Bristol Myers Squibb India Pvt. Ltd. 3. Nivolumab (Opdyta) OASIS Bristol Myers Squibb India Pvt. Ltd. 4. Halaven (Eribulin medylate) Hope to Her - Eisai Pharmaceuticals India Pvt. Soft Tissue Sarcoma free upto disease progression HELP - Eisai Pharmaceuticals India Pvt. All cycles free for below poverty Ltd. line patients 5. Zonegran (Zonisamide) - Livefree - 33% Eisai Pharmaceuticals India Pvt. for Epilespy Support to patients for extending Ltd. duration of treatment as this is a chronic therapy 6. Imbruvica 1+1 PAP Janssen India, Johnson & Johnson Pvt. Ltd. 7. Zytiga 3+1 PAP Janssen India, Johnson & Johnson Pvt. Ltd. 8. Velcade 1mg 3+1 PAP Janssen India, Johnson & Johnson Pvt. Ltd. 9. Velcade 3.5 mg 1+1 PAP Janssen India, Johnson & Johnson Pvt. Ltd. 10. Caelax 1+1 PAP Janssen India, Johnson & Johnson Pvt. Ltd. 11. Dacogen 1+1 PAP Janssen India, Johnson & Johnson Pvt. Ltd. 12. Yondelis 1+1 PAP Janssen India, Johnson & Johnson Pvt. Ltd. 13. Simponi 1 vial free on 1st purchase Janssen India, Johnson & Johnson Pvt. Ltd. 14. Remicade 5+4 on 3 dose therapy, 6+6 on Janssen India, Johnson & 4 dose therapy Johnson Pvt. Ltd. 15. Invega all SKUs 1+1 PAP (Maintenance dosage) Janssen India, Johnson & Johnson Pvt. Ltd. 16. Imatinib (Glivec) Glivec NOA Program/ Glivec Novartis India Ltd. International PAP 17. Nilotinib (Tasigna) Win for Patients- Cancer Care/ Novartis Healthcare Private. Umaang Limited 18. Ruxolitinib (Jakavi) Win for Patients- Cancer Care/ Novartis Healthcare Private Umaang Limited 19. Everolimus (Afinitor) Win for Patients- Cancer Care/ Novartis Healthcare Private Umaang Limited 20. Ceritinib (Spexib) Win for Patients- Cancer Care/ Sandoz India Private Limited Umaang 21. Pazopanib (Votrient) Win for Patients- Cancer Care/ Novartis Healthcare Private Umaang Limited 22. Eltrombopag (Revolade) Win for Patients- Cancer Care/ Novartis Healthcare Private Umaang Limited 23. Indicaterol (Sequadra) Win for Patients - COPD Novartis India Ltd. 24. Secukinumab (Scapho) Win for Patients - Skincare Novartis India Ltd. 25. Omalizumab (Xolair CSU) Win for Patients - Skin care Novartis India Ltd. 26. Ranibizumab (Accentrix) Win for Patients - Visioncare Novartis India Ltd. 27. RITUXIMAB SPARSH - The Touch Dr. Reddy's Laboratories Ltd. 28. Erlotinib (Tarceva) The Blue Tree Roche Products (India) Private Limited 29. Trastuzumab (Herclon) The Blue Tree Roche Products (India) Private Limited 30. Pertuzumab (Perjeta) The Blue Tree Roche Products (India) Private Limited 31. Transtuzumab Emtansine The Blue Tree Roche Products (Kadcyla) (India) Private Limited 32. Obinutuzumab (Gazyva) The Blue Tree Roche Products (India) Private Limited 33. Bevacizumab (Avastin) The Blue Tree Roche Products (India) Private Limited 34. Tocilizumab (Actemra) Care for Joints Roche Products (India) Private Limited 35. Mycophenolate Aarambh Roche Products Mofetil (CellCept) (India) Private Limited 36. Avonex (Interferon Reach UCB India Private Limited Beta 1A) 37. Tysabri (Monoclonal Reach UCB India Private Limited Antibody 38. Tecfidera (Di-methyl Reach UCB India Private Limited Fumarate) 39. Plegridy (Peggylated Reach UCB India Private Limited Interferon Beta 1A) 40. Sorafenib (Nexavar) NexCSP (Nexavar Cancer Bayer ZydusPharma Private Survivorship Program) Limited 41. Sirturo (Bedaquiline) Bedaquiline Compassionate Janssen India, Johnson & Use Program Johnson Private Limited 42. Darzalex (Daratumumab) Daratumumab Patient Janssen India, Johnson & Assistance Program Johnson Private Limited 43. SUTENT Sutent Patient Assistance Programme - Pfizer Products India Private STAR Limited -Full subsidy for BPL patients 44. CRIZALK Crizalk Patient Assistance Programme- Pfizer Products India Private STAR Limited 45. INLYTA Inlyta Patient Assistance Programme - Pfizer Products India Private STAR Limited 46. PALBACE Palbace Patient Assistance Pfizer Products India Private Programme- PRERNA Limited 47. ENBREL Enbrel Patient Assistance Pfizer Limited 48. XELJANZ Xeljanz Patient Assistance Pfizer Limited 49. GENPTROPIN Genotropin Patient Assistance Pfizer Products India Private Programme Limited 50. Atgam Atgam Patient Assistance Programme Pfizer Products India Private Limited 51. Aromasin Aromasin Patient Assistance Pfizer Products India Private Programme Limited 52. Campto Campto Patient Assistance Programme Pfizer Products India Private Limited 1[53.Pembrolizumab Key- PAP 1.0 MSD Pharmaceuticals 54. Pembrolizumab KIRAN MSD Pharmaceuticals 55. Lorlatinib LorbriquaCare Pfizer Products India Private Ltd. 56. Dacomitinib DacoCare Pfizer Products India Private Ltd. 57. Inotuzumab Ozogamicin HemaCare Pfizer Products India Private Ltd. 58. Ribociclib UMAANG Novartis Healthcare Pvt. Ltd. 59. Dabrafenib UMAANG Novartis Healthcare Pvt. Ltd. 60. Selumetinib AstraZeneca Pharma PAP AstraZeneca Pharma India Limited 1 Inserted by Notification No. 09/2025 - Customs, dated 01.02.2025 w.e.f. 02.02.2025. 61. Benralizumab AstraZeneca Pharma PAP AstraZeneca Pharma India Limited 62. Fulvestrant AstraZeneca Pharma PAP AstraZeneca Pharma India Limited 63. Acalabrutinib AstraZeneca Pharma PAP AstraZeneca Pharma India Limited 64. Olaparib AstraZeneca Pharma PAP AstraZeneca Pharma India Limited 65. Amivantamab Johnson and Johnson PAP Johnson & Johnson Pvt. Ltd. 66. Teclistamab Johnson and Johnson PAP Johnson & Johnson Pvt. Ltd. 67. Ustekinumab Johnson and Johnson PAP Johnson & Johnson Pvt. Ltd. 68. Daratumumab Johnson and Johnson PAP Johnson & Johnson Pvt. Ltd. And hyaluronidase-fihj 69. Ibrutinib Johnson and Johnson PAP Johnson & Johnson Pvt. Ltd. 70. Bortezomib Johnson and Johnson PAP Johnson & Johnson Pvt. Ltd. 71. Daratumumab Johnson and Johnson PAP Johnson & Johnson Pvt. Ltd. 72. Cetuximab Rainbow PAP Merck Specialties Pvt. Ltd. 73. Avelumab My Bavencio Assist Merck Specialties Pvt. Ltd. Program 74. Tepotinib My Tepmetko Patient Access Merck Specialties Pvt. Ltd. Program 75. Brentuximab Vedotin Takeda PAP Takeda Biopharmaceuticals India Pvt. Limited 76. Vedolizumab Takeda PAP Takeda Biopharmaceuticals India Pvt. Limited 77. Velaglucerase Alpha Takeda PAP Takeda Biopharmaceuticals India Pvt. Limited 78. Agalsidase Alpha Takeda PAP Takeda Biopharmaceuticals India Pvt. Limited 79. Idursulphase Takeda PAP Takeda Biopharmaceuticals India Pvt. Limited 80. Mepolizumab GSK Pharmaceuticals Limited GSK Pharmaceuticals Limited 81. Alectinib The Blue Tree Roche Products India Private Ltd. 82. Risdiplam Powder The Blue Tree Roche Products India Private Ltd. 83. Emicizumab The Blue Tree Roche Products India Private Ltd. 84. Atezolizumab The Blue Tree Roche Products India Private Ltd. 85. Pertuzumab + The Blue Tree Roche Products India Private trastuzumab Ltd. 86. Ocrelizumab The Blue Tree Roche Products India Private Ltd. 87. Polatuzumab vedotin The Blue Tree Roche Products India Private Ltd. 88. Faricimab The Blue Tree Roche Products India Private Ltd. 89. Luspatercept Bristol-Myers Patient Bristol-Myers Squibb India Pvt. Assistance Program Ltd.]

Back to HSN Code Finder
Source: CBIC Part II Import Tariff, chapter-wise PDFs·Indian Customs Tariff — First Schedule (as on 30.06.2024, CBIC)

Effective import duty stack

Live values from India's ICEGATE customs calculator, computed on an assessable value of ₹100.

Unitkg.
BCD10%₹10.00
AIDC10%₹1.00
SWS10%₹1.10
IGST18%₹20.18Notif. 009/2025-II38
Total Duty32.28%≈ ₹32.28 per ₹100 of CIF
How it's calculated

For an assessable value of ₹100:

  1. BCD = AV × 10% = ₹10.00
  2. AIDC = BCD × 10% = ₹1.00
  3. SWS = (BCD + AIDC) × 10% = ₹1.10(exemption notifications exist for this code; verify eligibility)
  4. IGST = (AV + BCD + AIDC + SWS) × 18% = ₹20.18
  5. Total Duty = BCD + AIDC + SWS + IGST = ₹32.28 (32.28%)

Notifications and exemptions can lower the effective rate for specific goods or FTA partner countries. Cross-check against the latest CBIC circulars before filing.

FTA preferential rates

Basic Customs Duty (BCD) under each Free Trade Agreement India is party to. Sourced from ITC's Market Access Map (MACMAP, 2025). Other duties (AIDC, SWS, IGST, Cess) typically still apply on top — see the Effective duty stack above for those.

Best rate0%via Least Developed Countries(−10 pp vs MFN)
MFN (no FTA)
10%
baseline
Least Developed CountriesBest
0%
−10 pp vs MFN
Nepal
0%
−10 pp vs MFN
SAFTA (LDC) countries
0%
−10 pp vs MFN
Sri Lanka
0%
−10 pp vs MFN
SAFTA countries
5%
−5 pp vs MFN
Source: ITC MACMAP · 2025 · Eligibility depends on Rules of Origin (RoO) — consult the relevant FTA notification before filing.

Customs Compliance Requirements published on ICEGATE for this tariff item — covers BIS / DOT / EPR / quarantine etc. Click to expand.

Where this code sits

Section VI
PRODUCTS OF THE CHEMICAL OR ALLIED INDUSTRIES
Chapter 30
Pharmaceutical products
Tariff hierarchy
  1. 1
    3006Heading (4-digit)
    PHARMACEUTICAL GOODS SPECIFIED IN NOTE 4 TO THIS CHAPTER
  2. 2
    30069300Tariff Item (8-digit)
    Placebos and blinded (or double-blinded) clinical trial kits for a recognised clinical trial, put up in measured doses DRUGS AND MEDICINES ARE SUPPLIED FREE OF COST TO THE PATIENTS UNDER THE PATIENT ASSISTANCE PROGRAMME OF THE SPECIFIED PHARMACEUTICAL COMPANY: [Notifn. No. 16/2017-Cus., dt. 20.4. 2017 as amended by 83/17, 41/20, 09/22, 07/24]. In exercise of the powers conferred by sub-section (1) of section 25 of the Customs Act, 1962 (52 of 1962), the Central Government, being satisfied that it is necessary in the public interest so to do, hereby exempts the goods, falling under Chapter 30 of the First Schedule to the Customs Tariff Act, 1975 (51 of 1975), of the description specified in column (2) of the Table below, for supply under Patient Assistance Programmes specified in the corresponding entry in column (3) of the said Table, run by the pharmaceutical companies specified in the corresponding entry in column (4) of the said Table, when imported into India, from the whole of the duty of customs leviable thereon which is specified in the First Schedule to the said Customs Tariff Act, subject to the following conditions, namely:- (a) the drugs and medicines are supplied free of cost to the patients under the Patient Assistance Programme of the specified pharmaceutical company; (b) the said pharmaceutical company furnishes an undertaking to the Assistant Commissioner of Customs or the Deputy Commissioner of Customs, as the case may be, having jurisdiction, to the effect that- (i) it shall maintain the following records:- (A) name, age, gender, residence and contact details of the patient; (B) copies of valid identity proof and residence proof of the patient and the caregiver, if any, as the case may be; (C) the disease diagnosed and the prescribed dosage of drugs and medicines; (D) the drugs and medicines imported or received and consumed under the said programme; (ii) the goods shall be used for the specified purpose only; (c) The said pharmaceutical company also furnishes an undertaking to the Assistant Commissioner of Customs or Deputy Commissioner of Customs, as the case may be, having jurisdiction, to pay, in the event of failure to comply with any of the aforesaid conditions, an amount equal to the duty leviable on such goods but for the exemption contained in this notification, along with the applicable interest thereon. TABLE Sr. Description of drug Name of Patient Name of No. / medicine Assistance Programme pharmaceutical company running Patient Assistance Programme 1. Xtandi (Enzulatamide) Xtandi Patient Assistance Programme Astellas Pharma India Pvt. Ltd. 2. Dasatinib (Sprycel) Sprycel Assistance Program Bristol Myers Squibb India Pvt. Ltd. 3. Nivolumab (Opdyta) OASIS Bristol Myers Squibb India Pvt. Ltd. 4. Halaven (Eribulin medylate) Hope to Her - Eisai Pharmaceuticals India Pvt. Soft Tissue Sarcoma free upto disease progression HELP - Eisai Pharmaceuticals India Pvt. All cycles free for below poverty Ltd. line patients 5. Zonegran (Zonisamide) - Livefree - 33% Eisai Pharmaceuticals India Pvt. for Epilespy Support to patients for extending Ltd. duration of treatment as this is a chronic therapy 6. Imbruvica 1+1 PAP Janssen India, Johnson & Johnson Pvt. Ltd. 7. Zytiga 3+1 PAP Janssen India, Johnson & Johnson Pvt. Ltd. 8. Velcade 1mg 3+1 PAP Janssen India, Johnson & Johnson Pvt. Ltd. 9. Velcade 3.5 mg 1+1 PAP Janssen India, Johnson & Johnson Pvt. Ltd. 10. Caelax 1+1 PAP Janssen India, Johnson & Johnson Pvt. Ltd. 11. Dacogen 1+1 PAP Janssen India, Johnson & Johnson Pvt. Ltd. 12. Yondelis 1+1 PAP Janssen India, Johnson & Johnson Pvt. Ltd. 13. Simponi 1 vial free on 1st purchase Janssen India, Johnson & Johnson Pvt. Ltd. 14. Remicade 5+4 on 3 dose therapy, 6+6 on Janssen India, Johnson & 4 dose therapy Johnson Pvt. Ltd. 15. Invega all SKUs 1+1 PAP (Maintenance dosage) Janssen India, Johnson & Johnson Pvt. Ltd. 16. Imatinib (Glivec) Glivec NOA Program/ Glivec Novartis India Ltd. International PAP 17. Nilotinib (Tasigna) Win for Patients- Cancer Care/ Novartis Healthcare Private. Umaang Limited 18. Ruxolitinib (Jakavi) Win for Patients- Cancer Care/ Novartis Healthcare Private Umaang Limited 19. Everolimus (Afinitor) Win for Patients- Cancer Care/ Novartis Healthcare Private Umaang Limited 20. Ceritinib (Spexib) Win for Patients- Cancer Care/ Sandoz India Private Limited Umaang 21. Pazopanib (Votrient) Win for Patients- Cancer Care/ Novartis Healthcare Private Umaang Limited 22. Eltrombopag (Revolade) Win for Patients- Cancer Care/ Novartis Healthcare Private Umaang Limited 23. Indicaterol (Sequadra) Win for Patients - COPD Novartis India Ltd. 24. Secukinumab (Scapho) Win for Patients - Skincare Novartis India Ltd. 25. Omalizumab (Xolair CSU) Win for Patients - Skin care Novartis India Ltd. 26. Ranibizumab (Accentrix) Win for Patients - Visioncare Novartis India Ltd. 27. RITUXIMAB SPARSH - The Touch Dr. Reddy's Laboratories Ltd. 28. Erlotinib (Tarceva) The Blue Tree Roche Products (India) Private Limited 29. Trastuzumab (Herclon) The Blue Tree Roche Products (India) Private Limited 30. Pertuzumab (Perjeta) The Blue Tree Roche Products (India) Private Limited 31. Transtuzumab Emtansine The Blue Tree Roche Products (Kadcyla) (India) Private Limited 32. Obinutuzumab (Gazyva) The Blue Tree Roche Products (India) Private Limited 33. Bevacizumab (Avastin) The Blue Tree Roche Products (India) Private Limited 34. Tocilizumab (Actemra) Care for Joints Roche Products (India) Private Limited 35. Mycophenolate Aarambh Roche Products Mofetil (CellCept) (India) Private Limited 36. Avonex (Interferon Reach UCB India Private Limited Beta 1A) 37. Tysabri (Monoclonal Reach UCB India Private Limited Antibody 38. Tecfidera (Di-methyl Reach UCB India Private Limited Fumarate) 39. Plegridy (Peggylated Reach UCB India Private Limited Interferon Beta 1A) 40. Sorafenib (Nexavar) NexCSP (Nexavar Cancer Bayer ZydusPharma Private Survivorship Program) Limited 41. Sirturo (Bedaquiline) Bedaquiline Compassionate Janssen India, Johnson & Use Program Johnson Private Limited 42. Darzalex (Daratumumab) Daratumumab Patient Janssen India, Johnson & Assistance Program Johnson Private Limited 43. SUTENT Sutent Patient Assistance Programme - Pfizer Products India Private STAR Limited -Full subsidy for BPL patients 44. CRIZALK Crizalk Patient Assistance Programme- Pfizer Products India Private STAR Limited 45. INLYTA Inlyta Patient Assistance Programme - Pfizer Products India Private STAR Limited 46. PALBACE Palbace Patient Assistance Pfizer Products India Private Programme- PRERNA Limited 47. ENBREL Enbrel Patient Assistance Pfizer Limited 48. XELJANZ Xeljanz Patient Assistance Pfizer Limited 49. GENPTROPIN Genotropin Patient Assistance Pfizer Products India Private Programme Limited 50. Atgam Atgam Patient Assistance Programme Pfizer Products India Private Limited 51. Aromasin Aromasin Patient Assistance Pfizer Products India Private Programme Limited 52. Campto Campto Patient Assistance Programme Pfizer Products India Private Limited 1[53.Pembrolizumab Key- PAP 1.0 MSD Pharmaceuticals 54. Pembrolizumab KIRAN MSD Pharmaceuticals 55. Lorlatinib LorbriquaCare Pfizer Products India Private Ltd. 56. Dacomitinib DacoCare Pfizer Products India Private Ltd. 57. Inotuzumab Ozogamicin HemaCare Pfizer Products India Private Ltd. 58. Ribociclib UMAANG Novartis Healthcare Pvt. Ltd. 59. Dabrafenib UMAANG Novartis Healthcare Pvt. Ltd. 60. Selumetinib AstraZeneca Pharma PAP AstraZeneca Pharma India Limited 1 Inserted by Notification No. 09/2025 - Customs, dated 01.02.2025 w.e.f. 02.02.2025. 61. Benralizumab AstraZeneca Pharma PAP AstraZeneca Pharma India Limited 62. Fulvestrant AstraZeneca Pharma PAP AstraZeneca Pharma India Limited 63. Acalabrutinib AstraZeneca Pharma PAP AstraZeneca Pharma India Limited 64. Olaparib AstraZeneca Pharma PAP AstraZeneca Pharma India Limited 65. Amivantamab Johnson and Johnson PAP Johnson & Johnson Pvt. Ltd. 66. Teclistamab Johnson and Johnson PAP Johnson & Johnson Pvt. Ltd. 67. Ustekinumab Johnson and Johnson PAP Johnson & Johnson Pvt. Ltd. 68. Daratumumab Johnson and Johnson PAP Johnson & Johnson Pvt. Ltd. And hyaluronidase-fihj 69. Ibrutinib Johnson and Johnson PAP Johnson & Johnson Pvt. Ltd. 70. Bortezomib Johnson and Johnson PAP Johnson & Johnson Pvt. Ltd. 71. Daratumumab Johnson and Johnson PAP Johnson & Johnson Pvt. Ltd. 72. Cetuximab Rainbow PAP Merck Specialties Pvt. Ltd. 73. Avelumab My Bavencio Assist Merck Specialties Pvt. Ltd. Program 74. Tepotinib My Tepmetko Patient Access Merck Specialties Pvt. Ltd. Program 75. Brentuximab Vedotin Takeda PAP Takeda Biopharmaceuticals India Pvt. Limited 76. Vedolizumab Takeda PAP Takeda Biopharmaceuticals India Pvt. Limited 77. Velaglucerase Alpha Takeda PAP Takeda Biopharmaceuticals India Pvt. Limited 78. Agalsidase Alpha Takeda PAP Takeda Biopharmaceuticals India Pvt. Limited 79. Idursulphase Takeda PAP Takeda Biopharmaceuticals India Pvt. Limited 80. Mepolizumab GSK Pharmaceuticals Limited GSK Pharmaceuticals Limited 81. Alectinib The Blue Tree Roche Products India Private Ltd. 82. Risdiplam Powder The Blue Tree Roche Products India Private Ltd. 83. Emicizumab The Blue Tree Roche Products India Private Ltd. 84. Atezolizumab The Blue Tree Roche Products India Private Ltd. 85. Pertuzumab + The Blue Tree Roche Products India Private trastuzumab Ltd. 86. Ocrelizumab The Blue Tree Roche Products India Private Ltd. 87. Polatuzumab vedotin The Blue Tree Roche Products India Private Ltd. 88. Faricimab The Blue Tree Roche Products India Private Ltd. 89. Luspatercept Bristol-Myers Patient Bristol-Myers Squibb India Pvt. Assistance Program Ltd.]

What is an HSN Code?

An HSN code (Harmonized System of Nomenclature) is an internationally standardised numeric system to classify traded products. Indian customs extend it to an 8-digit ITC-HS code for more precise classification, taxation and compliance.

  • First 2 digits: Chapter (e.g. 30)
  • Digits 3–4: Heading
  • Digits 5–6: Subheading (WCO-aligned)
  • Last 2 digits: Indian ITC extension for added granularity
Chapter30
Heading3006
Subheading300693
Tariff Item30069300

Why is the right HSN code important?

  • Ensures correct calculation of customs duties and taxes.
  • Required for shipping bills, bills of entry, GST filings and FTA certificates of origin.
  • Helps avoid clearance delays, penalties or reclassification disputes.
Tip: Always cross-check the 8-digit code against the latest DGFT / Customs schedule before filing.

How to use this HSN code

Export Documentation

Use this code in your Commercial Invoice, Packing List, and Shipping Bill for exports from India.

Import Clearance

Required for the Bill of Entry and customs clearance when importing goods into India.

GST Classification

Drives the applicable GST rate, HSN-wise summary in GSTR-1 and ITC eligibility checks.

Common HSN code mistakes to avoid

  • • Reusing outdated or incorrect codes from old shipments
  • • Mixing up similar product codes without checking descriptions
  • • Ignoring the last 2 digits which affect Indian duty rates
  • • Not considering composition, end use or manufacturing process
  • • Relying solely on online tools without professional verification

Need more information?

For complex products, consult with customs brokers or trade experts who can classify based on:

  • • Physical product inspection
  • • Material composition / manufacturing process
  • • Intended end-use
  • • Latest customs notifications & advance rulings
Pro tip: Correct HSN code usage saves time, money and grief at customs.

Additional Resources

• DGFT Policy: Guidelines for export-import procedures

• Customs Tariff: Complete HSN code list with duty rates

• GST Notifications: Latest tax-rate updates

• Trade Portal: Government trade documentation support

Related EximPe tools

Free, no signup — same trade-and-payments toolset your team uses to move money across borders.

SWIFT Code Finder

Verify SWIFT/BIC codes for global bank transfers. By country, city, or bank.

Open tool

Currency Converter

Live mid-market FX rates for 150+ currencies. Inbound INR conversions for exporters.

Open tool

Invoice Generator

Build a cross-border invoice in minutes. Edit fields inline, export to PDF.

Open tool

EximPe Support

EximPe SupportHi there! 👋
How can we help you with your global payments today?
Start Chat